Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women

Holy Family Hospital, Nazareth, Israel

Status: Enrolling

Conditions: Breakthrough Pain

Treatments: Drug: continuous epidural infusion; Drug: programmed intermittent Bolus epidural analgesia

Study type: Interventional

Funder types: Other

Identifiers

NCT06580327

298\2024 HFH

Details and patient eligibility

About

The goal of this randomized controlled trial is to examine the impact of programmed intermittent bolus epidural analgesia technique on the incidence of breakthrough pain during labor in multiparous women compared to continuous epidural infusion.

multiparous women will randomly be divided during labor into two groups; study group will receive mix of Bupivacaine and fentanyl once (bolus) every 60 minutes; the control group will receive continuously the same dose during an hour, until delivery.

Full description

There are several pharmacological and non-pharmacological techniques for pain relief during labor. Epidural analgesia is considered the most effective modality for intrapartum pain relief.

Maintenance of epidural analgesia is achieved by different techniques; continuous epidural infusion (CEI), intermittent epidural analgesia (IEA), patient control epidural analgesia (PCEA) and combination between the techniques.

Another technique, the Programmed Intermittent Bolus Epidural Analgesia (PIBEA). The advantage of this technique is that boluses are given all the time at planned intervals, so laboring women do not depend on the medical staff to receive the bolus when there is a breakthrough pain.

This method has been reported to be associated with less motor block, lower incidence of instrumental vaginal deliveries, and less consumption of anesthetic agents when compared to CEI. There are no conclusive data regarding the use of PIBEA in combination with PCEA compared to CEI and PCEA on the effect of pain relief during labor and birth outcomes. The hypothesis of the current trial is that PIBEA and PCEA will decrease the incidence of breakthrough pain, and probably shorten the second stage of labor, lead to fewer instrumental deliveries and higher women's satisfaction compared to CEI and PCEA.

Enrollment: 186 estimated patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. multiparous women
2. Term pregnancy
3. Singleton
4. Vertex presentation
5. Latent phase (cervical dilatation less than 6 cm)
6. Epidural analgesia request
7. Visual Analogue Scale score greater than 40

Exclusion criteria

1. Estimated fetal weight greater than 4.0 kg

2. Intra uterine fetal death

3. Drug sensitivity

4. Anomalous fetus 6. Contraindication for epidural analgesia

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

186 participants in 2 patient groups

study group

Active Comparator group

Description:

Epidural analgesia will be maintained by receiving programmed intermittent 10ml bolus of 0.1% Bupivacaine and 2microgram\\ml Fentanyl every one hour, until the delivery is completed, and lacerations are sutured.

Treatment:

Drug: programmed intermittent Bolus epidural analgesia

control group

Active Comparator group

Description:

Epidural analgesia will be maintained by receiving 10ml\\h continuous infusion of 0.1% Bupivacaine and 2microgram\\ml Fentanyl until the delivery is completed, and lacerations are sutured.

Treatment:

Drug: continuous epidural infusion